Shoulder Innovations (SI) Q2 FY26 earnings call

Shoulder Innovations delivered strong Q2 FY26 results, marked by significant revenue growth and gross margin expansion, driven by accelerated new surgeon adoption and increased utilization within its customer base. The company raised its full-year revenue guidance, reflecting high conviction in its commercial strategy and a robust product pipeline, including advancements in robotic surgery and next-generation implant systems. Management emphasized the strategic importance of its ProVoyance platform and new partnerships in expanding market reach.